NCT07626775Completed
To Assess the Prevalence, Management Practices, and Clinical Outcomes Associated With Hyperglycemia Among Hospitalized Patients, With a Particular Focus on the Interplay Between Metabolic Biomarkers, Nutritional Status, and Body Composition
Source: ClinicalTrials.gov · Last updated 4 Jun 2026
Brief summary (registry, in English)
This was a prospective, observational cross-sectional study conducted at a tertiary care private hospital in India. The study was designed to comprehensively evaluate the prevalence, management strategies, and clinical outcomes of in-hospital hyperglycemia among adult inpatients. The study also explored the associations of metabolic biomarkers-fetuin-A and fibroblast growth factor-21 (FGF-21) as well as sarcopenic obesity and nutritional factors with clinical outcomes, including length of hospital stay (LOS), complications, and mortality. Institutional Ethics Committee approval was obtained prior to study initiation, and written informed consent was secured from all participants
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 362 (actual)
- First submitted
- 14 May 2026
- Start date
- 1 Jan 2023
- Primary completion date
- 1 Feb 2026
- Lead sponsor
- Medanta, The Medicity, India
- Diseases
- Type 2 diabetes
- NCT number
- NCT07626775
What you commit to
- Study type: Observational
- Participants enrolled: 362
- From 1 Jan 2023 to the primary completion date, 1 Feb 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with type 1 diabetes mellitus or other specific types of diabetes (e.g., pancreatogenic, drug-induced).
- Patients with chronic liver disease unrelated to diabetes or hepatic dysfunction secondary to viral hepatitis, autoimmune hepatitis, or alcohol abuse.
- Critically ill patients requiring palliative care or those with advanced malignancy
Other
- Pregnant or lactating women.
Who the study is looking for
- Adult patients aged ≥18 years.
- Patients with known or newly diagnosed type 2 diabetes mellitus (T2DM) or those presenting with hyperglycemia (random blood glucose ≥140 mg/dL) during hospitalization.
- Both medical and surgical inpatients admitted for ≥24 hours
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Division Of Endocrinology & Diabetes Coordinator of this site? Confirm its status | Gurgaon | India | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.